- Home
- NVVE vs XXII Comparison
NVVE vs XXII Comparison
Compare NVVE & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVVE
- XXII
- Stock Information
- Founded
- NVVE 1996
- XXII 1998
- Country
- NVVE United States
- XXII United States
- Employees
- NVVE N/A
- XXII N/A
- Industry
- NVVE Oil Refining/Marketing
- XXII Medicinal Chemicals and Botanical Products
- Sector
- NVVE Energy
- XXII Health Care
- Exchange
- NVVE Nasdaq
- XXII Nasdaq
- Market Cap
- NVVE 2.8M
- XXII 2.8M
- IPO Year
- NVVE N/A
- XXII N/A
- Fundamental
- Price
- NVVE $2.97
- XXII $5.10
- Analyst Decision
- NVVE
- XXII
- Analyst Count
- NVVE 0
- XXII 0
- Target Price
- NVVE N/A
- XXII N/A
- AVG Volume (30 Days)
- NVVE 22.0K
- XXII 2.5M
- Earning Date
- NVVE 11-12-2024
- XXII 11-12-2024
- Dividend Yield
- NVVE N/A
- XXII N/A
- EPS Growth
- NVVE N/A
- XXII N/A
- EPS
- NVVE N/A
- XXII N/A
- Revenue
- NVVE $5,144,831.00
- XXII $17,304,000.00
- Revenue This Year
- NVVE $200.61
- XXII $56.94
- Revenue Next Year
- NVVE $109.43
- XXII $2.98
- P/E Ratio
- NVVE N/A
- XXII N/A
- Revenue Growth
- NVVE N/A
- XXII N/A
- 52 Week Low
- NVVE $2.58
- XXII $3.90
- 52 Week High
- NVVE $72.70
- XXII $581.85
- Technical
- Relative Strength Index (RSI)
- NVVE 45.44
- XXII 41.23
- Support Level
- NVVE $2.58
- XXII $4.80
- Resistance Level
- NVVE $4.00
- XXII $12.49
- Average True Range (ATR)
- NVVE 0.33
- XXII 2.00
- MACD
- NVVE -0.03
- XXII 0.36
- Stochastic Oscillator
- NVVE 27.46
- XXII 3.90
About NVVE Nuvve Holding Corp.
Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.
About XXII 22nd Century Group Inc.
22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.